GlaxoSmithKline has created a contest for academic researchers that it hopes will accelerate the speed by which academic research can be turned into novel therapies.
The London pharmaceutical company, which has large operations in the Philadelphia region, on Tuesday launched a competition program it is calling Discovery Fast Track.
